Skip to content

Chartis Console

by Pulmonx, Inc. 2 variants

510(k) K083199

Chartis Console is a medical device (FDA Class II; FDA product code BZG, Spirometer, Diagnostic) made by Pulmonx, Inc., cleared under FDA 510(k) K083199 on 25 Jun 2009, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK083199 Date25 Jun 2009ClearedStatusActive

Official records

From the FDA record

Received by the FDA
30 Oct 2008
FDA decision
25 Jun 2009 (Substantially Equivalent)
FDA review time
238 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K083199 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
BZG
Device class
Class II
Regulation
21 CFR Part 868.1840
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code BZG (Spirometer, Diagnostic).

Other devices from Pulmonx Corporation

See all devices from Pulmonx Corporation →